These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26630543)

  • 1. Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis.
    Guo TT; Yang Y; Song Y; Ren Y; Liu ZX; Cheng G
    J Dig Dis; 2016 Jan; 17(1):11-9. PubMed ID: 26630543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midodrine in Liver Cirrhosis With Ascites: A Systematic Review and Meta-Analysis.
    Shrestha DB; Budhathoki P; Sedhai YR; Baniya RK; Karki P; Jha P; Mainali G; Acharya R; Sodhi A; Kadaria D
    Cureus; 2022 Jul; 14(7):e27483. PubMed ID: 36060403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
    Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
    J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.
    Singh V; Dheerendra PC; Singh B; Nain CK; Chawla D; Sharma N; Bhalla A; Mahi SK
    Am J Gastroenterol; 2008 Jun; 103(6):1399-405. PubMed ID: 18547224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
    Karwa R; Woodis CB
    Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival.
    Hanafy AS; Hassaneen AM
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1455-1461. PubMed ID: 27622998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study.
    Rai N; Singh B; Singh A; Vijayvergiya R; Sharma N; Bhalla A; Singh V
    Liver Int; 2017 Mar; 37(3):406-414. PubMed ID: 27614145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
    Singh V; Dhungana SP; Singh B; Vijayverghia R; Nain CK; Sharma N; Bhalla A; Gupta PK
    J Hepatol; 2012 Feb; 56(2):348-54. PubMed ID: 21749847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.
    Yosry A; Soliman ZA; Eletreby R; Hamza I; Ismail A; Elkady MA
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):345-351. PubMed ID: 30312183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
    Singh V; Singh A; Singh B; Vijayvergiya R; Sharma N; Ghai A; Bhalla A
    Am J Gastroenterol; 2013 Apr; 108(4):560-7. PubMed ID: 23419385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.
    Bai Z; An Y; Guo X; Teschke R; Méndez-Sánchez N; Li H; Qi X
    Can J Gastroenterol Hepatol; 2020; 2020():5106958. PubMed ID: 32676484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis.
    Bari K; Miñano C; Shea M; Inayat IB; Hashem HJ; Gilles H; Heuman D; Garcia-Tsao G
    Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1169-75. PubMed ID: 22801062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis.
    Shrestha DB; Budhathoki P; Sedhai YR; Baniya R; Awal S; Yadav J; Awal L; Davis B; Kashiouris MG; Cable CA
    Ann Hepatol; 2021 Dec; 26():100547. PubMed ID: 34626828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.
    Kalambokis G; Fotopoulos A; Economou M; Pappas K; Tsianos EV
    J Hepatol; 2007 Feb; 46(2):213-21. PubMed ID: 17156883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.
    Bai Z; Wang L; Wang R; Zou M; Méndez-Sánchez N; Romeiro FG; Cheng G; Qi X
    Hepatol Int; 2022 Dec; 16(6):1468-1483. PubMed ID: 36048318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midodrine for paracentesis-induced circulatory dysfunction.
    Bai M; Han G
    J Clin Gastroenterol; 2014 Mar; 48(3):300. PubMed ID: 24100756
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis.
    Facciorusso A; Chandar AK; Murad MH; Prokop LJ; Muscatiello N; Kamath PS; Singh S
    Lancet Gastroenterol Hepatol; 2017 Feb; 2(2):94-102. PubMed ID: 28403995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.